SEC Form 4 · accession 0001209191-17-001499
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred E Cohen
Director
Period of report
Jan 1, 2017
Accepted (ET)
Jan 4, 2017 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2017 | A | 340 | $29.39 | A | 65,578 | D | |
| Common Stock | holding | — | — | — | 6,068 | I | By the Jane K Cohen Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested.